Portal de Periódicos da CAPES

Artigo Produção Nacional

BIBTEX RIS

Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking

2020; American Scientific Publishers; Volume: 20; Issue: 12 Linguagem: Inglês

10.1166/jnn.2020.18955

1533-4899

Tiago da Silva Arouche, Arthur Ferreira Reis, Anderson Yuri Martins, José F. S. Costa, Raul Nunes de Carvalho, Antônio Maia de Jesus Chaves Neto,

thermodynamics and calorimetric analyses

We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and chloroquine interacting with the main COVID-19 protease in complex with a COVID-19 N3 protease inhibitor. The highest values of affinity energy found in order from highest to lowest were chloroquine (CHL), hydroxychloroquine (HYC), favipiravir (FAV), galidesivir (GAL), remdesivir (REM) and ribavirin (RIB). The possible formation of hydrogen bonds, associations through London forces and permanent electric dipole were analyzed. The values of affinity energy obtained for the hydroxychloroquine ligands was −9.9 kcal/mol and for the chloroquine of −10.8 kcal/mol which indicate that the coupling contributes to an effective improvement of the affinity energies with the protease. Indicating that, the position chosen to make the substitutions may be a pharmacophoric group, and cause changes in the protease.